JP2001520682A - 新規用途 - Google Patents
新規用途Info
- Publication number
- JP2001520682A JP2001520682A JP54454999A JP54454999A JP2001520682A JP 2001520682 A JP2001520682 A JP 2001520682A JP 54454999 A JP54454999 A JP 54454999A JP 54454999 A JP54454999 A JP 54454999A JP 2001520682 A JP2001520682 A JP 2001520682A
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen atom
- hydroxy
- groups
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.成人呼吸促進症候群の予防または治療向け医薬品の製造のためのマクロライ ド化合物の使用。 2.マクロライド化合物が下記一般式(I)で表されるトリシクロ化合物または その医薬として許容される塩である請求項1記載の使用。 (式中、R1およびR2、R3およびR4、R5およびR6の隣接するそれぞれの対は 、各々独立して、 a) 2つの隣接する水素原子を表すか、もしくはR2はアルキル基であっ てもよく、または b) 結合しているそれぞれの炭素原子どうしの間でもうひとつの結合を形 成してもよく; R7は水素原子、ヒドロキシ基、保護されたヒドロキシ基、もしくはアル キルオキシ基を表わすか、またはR1と共になってオキソ基を表わしてもよく; R8およびR9は独立して、水素原子、ヒドロキシ基を; R10は水素原子、アルキル基、1以上のヒドロキシ基によって置換され たアルキル基、アルケニル基、1以上のヒドロキシ基によって置換されたアルケ ニル基、またはオキソ基によって置換されたアルキル基を; Xはオキソ基、(水素原子、ヒドロキシ基)、(水素原子、水素原子)、または 式−CH2O−で表わされる基を; Yはオキソ基、(水素原子、ヒドロキシ基)、(水素原子、水素原子)、または 式N−NR11R12もしくはN−OR13で表わされる基を; R11およびR12は独立して水素原子、アルキル基、アリール基またはトシル 基を; R13、R14、R15、R16、R17、R18、R19、R22およびR23は独立して水 素原子またはアルキル基を; R24は、所望により置換されていてもよい、1以上の複素原子を含み得る環 ; nは1または2を表わす。 上記の意味に加え、さらにY、R10およびR23はそれらが結合している炭素原 子と一緒になって飽和もしくは不飽和の5員もしくは6員環からなる窒素原子、 硫黄原子および/もしくは酸素原子を含有する複素環基を表わしていてもよいが 、その複素環基は、アルキル基、ヒドロキシ基、アルキルオキシ基、ベンジル基 、式−CH2Se(C6H5)で表わされる基、および1以上のヒドロキシ基によ って置換されたアルキル基から選ばれる1以上の基によって置換されていてもよ い) 3.マクロライド化合物を哺乳動物に投与することからなる成人呼吸促進症候群 の治療または予防方法。 4.マクロライド化合物を担体または賦形剤と混合してなる成人呼吸促進症候群 の治療または予防のための医薬組成物。 5.成人呼吸促進症候群の治療または予防のためのマクロライド化合物の使用。 6.FK506物質である請求項1〜5に従って使用されるマクロライド。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP2231A AUPP223198A0 (en) | 1998-03-06 | 1998-03-06 | New use |
AU2231 | 1998-03-06 | ||
PCT/JP1999/001064 WO1999044597A2 (en) | 1998-03-06 | 1999-03-04 | Use of macrolide compounds for the treatment of ards |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001520682A true JP2001520682A (ja) | 2001-10-30 |
JP3367105B2 JP3367105B2 (ja) | 2003-01-14 |
Family
ID=3806495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54454999A Expired - Fee Related JP3367105B2 (ja) | 1998-03-06 | 1999-03-04 | 新規用途 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6333334B1 (ja) |
EP (1) | EP1059921B1 (ja) |
JP (1) | JP3367105B2 (ja) |
KR (1) | KR100395571B1 (ja) |
CN (1) | CN1133429C (ja) |
AT (1) | ATE244008T1 (ja) |
AU (1) | AUPP223198A0 (ja) |
BR (1) | BR9908796A (ja) |
CA (1) | CA2322027C (ja) |
DE (1) | DE69909257T2 (ja) |
DK (1) | DK1059921T3 (ja) |
ES (1) | ES2196840T3 (ja) |
HK (1) | HK1036406A1 (ja) |
PT (1) | PT1059921E (ja) |
WO (1) | WO1999044597A2 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
RU2470623C2 (ru) * | 2006-09-29 | 2012-12-27 | Инфа С.А. | Упаковка с фармацевтической композицией и комплект для внутривенного введения |
JP2010514790A (ja) * | 2006-12-28 | 2010-05-06 | リメリック バイオファーマ, インコーポレイテッド | 治療処置のための方法および組成物 |
ES2435197T3 (es) * | 2007-01-10 | 2013-12-16 | Board Of Regents, The University Of Texas System | Administración mejorada de composiciones de fármacos inmunosupresores para la administración por vía pulmonar |
CN101011414B (zh) * | 2007-01-29 | 2010-07-21 | 褚福明 | 一种肺脑合剂药物 |
KR20100051829A (ko) * | 2007-07-31 | 2010-05-18 | 리머릭 바이오파르마 인코오포레이티드 | 인산화된 피론 유사체 및 방법 |
CN101810633B (zh) * | 2010-03-31 | 2011-12-14 | 湖北丝宝药业有限公司 | 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途 |
GB201212773D0 (en) * | 2012-07-18 | 2012-08-29 | Ucl Business Plc | Vascular remodelling |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
GB2248184A (en) * | 1990-09-28 | 1992-04-01 | Fujisawa Pharmaceutical Co | New use of macrolide compounds for active oxygen-mediated diseases |
CA2054983A1 (en) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
AU8910891A (en) * | 1990-11-20 | 1992-06-11 | National Heart & Lung Institute, The | Treatment of lung diseases |
US5208241A (en) * | 1991-09-09 | 1993-05-04 | Merck & Co., Inc. | N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
US5290689A (en) * | 1992-09-28 | 1994-03-01 | Merck & Co., Inc. | New cyclic FR-900520 microbial biotransformation agent |
-
1998
- 1998-03-06 AU AUPP2231A patent/AUPP223198A0/en not_active Abandoned
-
1999
- 1999-03-04 DE DE69909257T patent/DE69909257T2/de not_active Expired - Lifetime
- 1999-03-04 KR KR10-2000-7009080A patent/KR100395571B1/ko not_active IP Right Cessation
- 1999-03-04 BR BR9908796-0A patent/BR9908796A/pt not_active Application Discontinuation
- 1999-03-04 US US09/623,595 patent/US6333334B1/en not_active Expired - Fee Related
- 1999-03-04 DK DK99937870T patent/DK1059921T3/da active
- 1999-03-04 JP JP54454999A patent/JP3367105B2/ja not_active Expired - Fee Related
- 1999-03-04 PT PT99937870T patent/PT1059921E/pt unknown
- 1999-03-04 EP EP99937870A patent/EP1059921B1/en not_active Expired - Lifetime
- 1999-03-04 WO PCT/JP1999/001064 patent/WO1999044597A2/en active IP Right Grant
- 1999-03-04 ES ES99937870T patent/ES2196840T3/es not_active Expired - Lifetime
- 1999-03-04 CN CNB998036676A patent/CN1133429C/zh not_active Expired - Fee Related
- 1999-03-04 AT AT99937870T patent/ATE244008T1/de not_active IP Right Cessation
- 1999-03-04 CA CA002322027A patent/CA2322027C/en not_active Expired - Fee Related
-
2001
- 2001-10-17 HK HK01107256A patent/HK1036406A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1059921A2 (en) | 2000-12-20 |
DE69909257D1 (de) | 2003-08-07 |
CN1133429C (zh) | 2004-01-07 |
CA2322027C (en) | 2009-05-12 |
BR9908796A (pt) | 2000-10-31 |
ATE244008T1 (de) | 2003-07-15 |
CN1292695A (zh) | 2001-04-25 |
EP1059921B1 (en) | 2003-07-02 |
AUPP223198A0 (en) | 1998-04-02 |
WO1999044597A3 (en) | 1999-12-29 |
PT1059921E (pt) | 2003-11-28 |
US6333334B1 (en) | 2001-12-25 |
DE69909257T2 (de) | 2004-02-19 |
HK1036406A1 (en) | 2002-01-04 |
WO1999044597A2 (en) | 1999-09-10 |
DK1059921T3 (da) | 2003-10-27 |
JP3367105B2 (ja) | 2003-01-14 |
KR100395571B1 (ko) | 2003-08-21 |
ES2196840T3 (es) | 2003-12-16 |
KR20010041046A (ko) | 2001-05-15 |
CA2322027A1 (en) | 1999-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3158437B2 (ja) | 眼疾患に対するマクロライド化合物の使用 | |
CA2274485C (en) | Medicinal composition | |
JP2002519378A (ja) | 疼痛の治療剤または予防剤を製造するためのfk506およびその類縁体の使用 | |
EP1056454A1 (en) | Use of macrolide compounds for treating glaucoma | |
US6864232B1 (en) | Agent for treating visual cell function disorder | |
JP5036934B2 (ja) | ドライアイ処置の為のマクロライド化合物の使用 | |
JPH05507915A (ja) | 特発性血小板減少性紫斑病およびバセドウ病治療薬製造のためのfk506等のマクロライド化合物の用途 | |
JP2001520682A (ja) | 新規用途 | |
WO2003043650A1 (en) | Use of fk506 and analogues for treating allergic diseases | |
AU687025B2 (en) | Use of macrolides for the treatment of cerebral ischemia | |
WO2000038703A1 (en) | Agent for treating visual cell function disorder | |
JP2003501382A (ja) | 軟骨形成性分化誘発のためのマクロライド化合物の新規用途 | |
GB2279006A (en) | Treatment of amyotrophic lateral sclerosis | |
JPH06183970A (ja) | 医薬用組成物 | |
ES et al. | VERWENDUNG VON MAKROLIDEN ZUR BEHANDLUNG VON AKUTEN LUNGENVERLETZUNGEN UTILISATION DE MACROLIDES POUR LE TRAITEMENT DES LESIONS DES POUMONS | |
KR20040002980A (ko) | 트리사이클릭 화합물을 포함하는 피부 질환의 예방 또는치료용 약제학적 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071108 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081108 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091108 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091108 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101108 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |